Key facts
- This page summarizes Emory Sayre de Castro's Form 4/A - Amendment filing for ADVENT TECHNOLOGIES HOLDINGS, INC. (ADN).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 14 Apr 2023, 16:45.
Key filing fact
Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
Sale
Sale
Additional SEC filing notes
Footnote F1
Aggregate number of shares sold on the same date at different prices. Shares sold by Reporting Person solely to satisfy income tax and withholding and remittance obligations in connection with the vesting and net settlement of Restricted Stock Units.
Footnote F2
Weighted average sale price. The shares were sold in multiple transactions at prices ranging from $1.974963 to $2.05, inclusive. Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission (the "Staff"), upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Footnote F3
Weighted average sale price. The shares were sold in multiple transactions at prices ranging from $1.93497 to $1.99499, inclusive. Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the Staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Footnote F4
Weighted average sale price. The shares were sold in multiple transactions at prices ranging from $1.90655 to $1.945296, inclusive. Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the Staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
SEC remarks
This Form 4 amendment is being filed to correct inadvertent errors in the Form 4 filed by Reporting Person on February 7, 2023.